Schroder Investment Management Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $884K | Sell |
51,704
-8,647
| -14% | -$148K | ﹤0.01% | 1006 |
|
|
2025
Q1 | $4.25M | Buy |
60,351
+54,828
| +993% | +$3.86M | ﹤0.01% | 789 |
|
|
2024
Q4 | $669K | Buy |
5,523
+2,320
| +72% | +$281K | ﹤0.01% | 1066 |
|
|
2024
Q3 | $399K | Sell |
3,203
-34,058
| -91% | -$4.24M | ﹤0.01% | 1131 |
|
|
2024
Q2 | $5.89M | Buy |
37,261
+20,075
| +117% | +$3.17M | 0.01% | 746 |
|
|
2024
Q1 | $2.22M | Sell |
17,186
-9,514
| -36% | -$1.23M | ﹤0.01% | 911 |
|
|
2023
Q4 | $2.57M | Buy |
+26,700
| New | +$2.57M | ﹤0.01% | 871 |
|
|
2021
Q2 | – | Sell |
-1,807
| Closed | -$135K | – | 1605 |
|
|
2021
Q1 | $135K | Hold |
1,807
| – | – | ﹤0.01% | 1358 |
|
|
2020
Q4 | $308K | Buy |
1,807
+1,204
| +200% | +$205K | ﹤0.01% | 1256 |
|
|
2020
Q3 | $81K | Hold |
603
| – | – | ﹤0.01% | 1247 |
|
|
2020
Q2 | $97K | Buy |
603
+229
| +61% | +$36.8K | ﹤0.01% | 1156 |
|
|
2020
Q1 | $38K | Buy |
+374
| New | +$38K | ﹤0.01% | 1237 |
|
|
2019
Q3 | – | Sell |
-1,201
| Closed | -$182K | – | 1315 |
|
|
2019
Q2 | $182K | Sell |
1,201
-1,117
| -48% | -$169K | ﹤0.01% | 1092 |
|
|
2019
Q1 | $276K | Buy |
+2,318
| New | +$276K | ﹤0.01% | 1047 |
|